Inflammatory-associated proteomic predictors of cognitive outcome in subjects with ELVO treated by mechanical thrombectomy
暂无分享,去创建一个
J. Harp | A. Stowe | K. Pennypacker | S. Pahwa | C. McLouth | L. Sheikhi | A. Trout | J. Frank | C. Rupareliya | J. Fraser | B. Maglinger | D. Dornbos
[1] Changde Wang,et al. Association of Blood Amyloid Beta-Protein 1-42 with Poststroke Cognitive Impairment: A Systematic Review and Meta-Analysis , 2022, BioMed research international.
[2] D. Lett,et al. A Longitudinal Study of Plasma pTau181 in Mild Cognitive Impairment with Lewy Bodies and Alzheimer's Disease , 2022, Movement disorders : official journal of the Movement Disorder Society.
[3] Ann M. Stowe,et al. Influence of BMI on adenosine deaminase and stroke outcomes in mechanical thrombectomy subjects , 2022, Brain, behavior, & immunity - health.
[4] Ann M. Stowe,et al. Antimicrobial protein REG3A and signaling networks are predictive of stroke outcomes , 2021, Journal of neurochemistry.
[5] Ann M. Stowe,et al. Intracranial VCAM1 at time of mechanical thrombectomy predicts ischemic stroke severity , 2021, Journal of Neuroinflammation.
[6] L. Falquet,et al. Revealing NOTCH-dependencies in synaptic targets associated with Alzheimer's disease , 2021, Molecular and Cellular Neuroscience.
[7] C. Lewis,et al. Long-Term Levels of LDL-C and Cognitive Function: The CARDIA Study , 2021, Journal of the International Neuropsychological Society.
[8] Jae-Yeol Joo,et al. Identifying New COVID-19 Receptor Neuropilin-1 in Severe Alzheimer’s Disease Patients Group Brain Using Genome-Wide Association Study Approach , 2021, Frontiers in Genetics.
[9] C. Raimondi,et al. Signalling, Metabolic Pathways and Iron Homeostasis in Endothelial Cells in Health, Atherosclerosis and Alzheimer’s Disease , 2020, Cells.
[10] P. Lewczuk,et al. Clinical significance of fluid biomarkers in Alzheimer’s Disease , 2020, Pharmacological Reports.
[11] Ann M. Stowe,et al. Proteomic changes in intracranial blood during human ischemic stroke , 2020, Journal of NeuroInterventional Surgery.
[12] Giuseppe De Vincentis,et al. Neuroimaging in vascular cognitive impairment and dementia: A systematic review. , 2020, Journal of Alzheimer's disease : JAD.
[13] G. Sirimarco,et al. Thrombectomy and Thrombolysis of Isolated Posterior Cerebral Artery Occlusion: Cognitive, Visual, and Disability Outcomes. , 2019, Stroke.
[14] J. Mocco,et al. Mortality reduction after thrombectomy for acute intracranial large vessel occlusion: meta-analysis of randomized trials , 2019, Journal of NeuroInterventional Surgery.
[15] M. Fornage,et al. Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke: A Meta-Analysis of Population-Based Studies Involving 17,180 Individuals. , 2019, Circulation research.
[16] K. Hultman,et al. Cartilage Oligomeric Matrix Protein Associates With a Vulnerable Plaque Phenotype in Human Atherosclerotic Plaques. , 2019, Stroke.
[17] H. Chiou,et al. Plasma Amyloid Beta and Tau Levels Are Predictors of Post-stroke Cognitive Impairment: A Longitudinal Study , 2019, Front. Neurol..
[18] K. Pennypacker,et al. The Blood And Clot Thrombectomy Registry And Collaboration (BACTRAC) protocol: novel method for evaluating human stroke , 2018, Journal of NeuroInterventional Surgery.
[19] H. Tammen,et al. The effect of DPP-4 inhibition to improve functional outcome after stroke is mediated by the SDF-1α/CXCR4 pathway , 2018, Cardiovascular Diabetology.
[20] C. Piperi,et al. DPP-4 inhibitors: a promising therapeutic approach against Alzheimer's disease. , 2018, Annals of translational medicine.
[21] Chunyan Zhu,et al. Targeting CCR3 to Reduce Amyloid-β Production, Tau Hyperphosphorylation, and Synaptic Loss in a Mouse Model of Alzheimer’s Disease , 2017, Molecular Neurobiology.
[22] J. Gornbein,et al. Ischemic Strokes Due to Large-Vessel Occlusions Contribute Disproportionately to Stroke-Related Dependence and Death: A Review , 2017, Front. Neurol..
[23] Peiyuan Lv,et al. Cognitive Function and Prognosis of Multimodal Neuroimage-Guided Thrombectomy on Mild to Moderate Anterior Circulation Infarction Patients with Broadened Therapeutic Window: A Prospective Study , 2017, European Neurology.
[24] E. López‐Cancio,et al. Endovascular treatment improves cognition after stroke , 2017, Neurology.
[25] D. Mukhopadhyay,et al. Neuropilin-1 modulates interferon-γ-stimulated signaling in brain microvascular endothelial cells , 2016, Journal of Cell Science.
[26] Rufus Akinyemi,et al. Stroke injury, cognitive impairment and vascular dementia , 2016, Biochimica et biophysica acta.
[27] M. Endres,et al. Circulating insulin-like growth factor binding protein-3 predicts one-year outcome after ischemic stroke. , 2015, Experimental and clinical endocrinology & diabetes.
[28] J. Gallacher,et al. The role of IGF-I, IGF-II, and IGFBP-3 in male cognitive aging and dementia risk: the Caerphilly Prospective Study. , 2014, Journal of Alzheimer's disease : JAD.
[29] N. Chattipakorn,et al. DPP-4 inhibitors improve cognition and brain mitochondrial function of insulin-resistant rats. , 2013, The Journal of endocrinology.
[30] G. Koh,et al. Is improvement in impaired cognition and depressive symptoms in post‐stroke patients associated with recovery in activities of daily living? , 2007, Acta neurologica Scandinavica.
[31] E. De Clercq,et al. CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3. , 1999, Journal of immunology.
[32] Y. Stern,et al. Cognitive impairment after stroke: frequency, patterns, and relationship to functional abilities. , 1994, Journal of neurology, neurosurgery, and psychiatry.
[33] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[34] S. Paolucci,et al. Predicting stroke inpatient rehabilitation outcome: the prominent role of neuropsychological disorders. , 1996, European neurology.